Table 5.
Settings | No. of studies | No. of patients | Sensitivity (95% CI) | Specificity (95% CI) | Pooled positive likelihood ratio (95% CI) | Pooled negative likelihood ratio (95% CI) | Diagnostic OR (95% CI) | Heterogeneity: I² |
Manea et al, 2014 SR–RA group | 7 | 4065 | 0.77 (0.70 to 0.84) | 0.94 (0.90 to 0.97) | 14.97 (8.39 to 26.71) | 0.23 (0.17 to 0.31) | 64.40 (34.15 to 121.43) | 78.9% |
Manea et al, 2014 SR Independent studies |
21 | 9900 | 0.48 (0.41 to 0.91) | 0.94 (0.91 to 0.95) | 8.26 (6.15 to 11.09) | 0.54 (0.48 to 0.62) | 15.05 (11.03 to 20.52) | 68.1% |
Moriarty et al, 2015 SR–RA group | 5 | 6188 | 0.87 (0.77 to 0.93) | 0.87 (0.76 to 0.94) | 7.24 (3.74 to 14.03) | 0.14 (0.08 to 0.25) | 49.31 (25.74 to 94.48) | 55.1% |
Moriarty et al, 2015 SR Independent studies | 26 | 13 164 | 0.76 (0.67 to 0.83) | 0.88 (0.85 to 0.91) | 6.72 (5.06 to 8.92) | 0.26 (0.19 to 0.37) | 24.96 (14.81 to 42.08) | 81.5% |
SR, Systematic review; RA,researcher allegiance.